BioNTech SE
Utility Patents
Last updated:
List of all BioNTech SE patents 9 in total
| Status | Patent |
|---|---|
Grant | Utility: Multispecific antibodies against CD40 and CD137 Filling date: 27 Sep 2025 Issue date: 13 Sep 2022 |
Grant | Utility: Preparation and storage of liposomal RNA formulations suitable for therapy Filling date: 27 Sep 2025 Issue date: 26 Jul 2022 |
Grant | Utility: Recombinant vaccines and use thereof Filling date: 27 Sep 2025 Issue date: 12 Apr 2022 |
Grant | Utility: Substituted imidazoquinolines as agonists of TLR7 Filling date: 27 Sep 2025 Issue date: 22 Mar 2022 |
Grant | Utility: Substituted imidazoquinolines Filling date: 27 Sep 2025 Issue date: 8 Mar 2022 |
Grant | Utility: Individualized vaccines for cancer Filling date: 27 Sep 2025 Issue date: 15 Feb 2022 |
Grant | Utility: Predicting immunogenicity of T cell epitopes Filling date: 27 Sep 2025 Issue date: 11 Jan 2022 |
Grant | Utility: Peptide mimotopes of the CD3 T-cell co-receptor epsilon chain and uses thereof Filling date: 27 Sep 2025 Issue date: 29 Jun 2021 |
Grant | Utility: Particles comprising protamine and RNA in combination with endosome destabilizing agents Filling date: 27 Sep 2025 Issue date: 4 Aug 2020 |
Showing 1 to 9 of 9 patents.